IN BRIEF: Jazz Pharma accuses Avadel of infringing Xyrem patents - Reuters
2:49pm PDT - May 13th, 2021 jazz - ReutersJazz Pharmaceuticals Inc accused Avadel Pharmaceuticals PLC of infringing five patents related to its blockbuster narcolepsy drug Xyrem in response to Avadel's plans to make its own narcolepsy drug, in a complaint entered Thursday in Delaware federal court.